Search results

  1. 1.
    0580041 - ÚOCHB 2024 RIV eng P - Patent Document
    Slusher, B. - Rais, R. - Riggins, G. - Majer, Pavel - Tichý, Tomáš - Vávra, Jan - Jančařík, Andrej - Tenora, Lukáš
    Mebendazole prodrugs with enhanced solubility and oral bioavailability.
    2023. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 14.09.2023. Patent Number: AU2019216757. Territorial Protection: národní patent v zemi mimo EU ,mezinárodní patentová ochrana dle Smlouvy o patentové spolupráci.
    Institutional support: RVO:61388963
    Keywords : mebendazole * prodrug * oral bioavailability
    OECD category: Medicinal chemistry
    https://worldwide.espacenet.com/patent/search/family/067549070/publication/AU2019216757B2?q=AU2019216757B2
    Permanent Link: https://hdl.handle.net/11104/0348822
     
     
  2. 2.
    0577575 - ÚOCHB 2024 RIV eng P - Patent Document
    Slusher, B. - Rais, R. - Riggins, G. - Majer, Pavel - Tichý, Tomáš - Vávra, Jan - Jančařík, Andrej - Tenora, Lukáš
    Mebendazole prodrugs with enhanced solubility and oral bioavailability.
    2023. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 01.08.2023. Patent Number: US11712435. Territorial Protection: národní patent v zemi mimo EU ,mezinárodní patentová ochrana dle Smlouvy o patentové spolupráci.
    Institutional support: RVO:61388963
    Keywords : mebendazole * prodrug * oral bioavailability
    OECD category: Medicinal chemistry
    https://worldwide.espacenet.com/patent/search/family/067549070/publication/US11712435B2?q=US11712435B2
    Permanent Link: https://hdl.handle.net/11104/0346694
     
     
  3. 3.
    0544774 - ÚOCHB 2022 RIV eng P - Patent Document
    Slusher, B. S. - Rais, R. - Vávra, Jan - Tichý, Tomáš - Majer, Pavel - Jančařík, Andrej - Tenora, Lukáš
    Prodrug compositions and utility of hydroxamate-based GCPII inhibitors.
    2021. Owner: The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 13.07.2021. Patent Number: US11059775
    Institutional support: RVO:61388963
    Keywords : hydroxamate * prodrugs * GCPII inhibitors
    OECD category: Organic chemistry
    https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=11059775B2&KC=B2&FT=D&ND=4&date=20210713&DB=&locale=en_EP
    Permanent Link: http://hdl.handle.net/11104/0321584
     
     


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.